Geroscience: just another name or is there more to it?

Aging Anti-aging medicine Biogerontology Demarcation Disease Geroscience Healthspan Lifespan Treatment

Journal

Biogerontology

ISSN: 1573-6768

Titre abrégé: Biogerontology

Pays: Netherlands

ID NLM: 100930043

Informations de publication

Date de publication:
15 May 2024

Historique:

received: 22 02 2024

accepted: 16 04 2024

medline: 15 5 2024

pubmed: 15 5 2024

entrez: 15 5 2024

Statut: aheadofprint

Résumé

The widespread use of the name 'geroscience' in the science of aging is sometimes met with a wary attitude by biogerontologists other than its inventors. Here, we provide an overview of its origin and evolution to assess what exactly it is and to discuss its theoretical and biological relationship to earlier movements of anti-aging medicine and biogerontology more generally. Geroscience posits that targeting aging may offer a cost-effective approach to improve late-life health in humans, and because aging is malleable in model organisms and what regulates this is sufficiently understood, the time is ripe for moving forward to translational and clinical research. The geroscience agenda has rebranded imagery of past traditions, yet the claim that therapies for human aging are ready or within the imminent future is contestable and on brand with tradition, even if biogerontology has made great progress in the past decades.

Identifiants

DOI: 10.1007/s10522-024-10105-x PMID: 38748334

pubmed: 38748334

doi: 10.1007/s10522-024-10105-x

pii: 10.1007/s10522-024-10105-x

doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Baker DJ, Wijshake T, Tchkonia T, LeBrasseur N, Childs BG, van de Sluis B, Kirkland JL, van Deursen J (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:232–236. https://doi.org/10.1038/nature10600

doi: 10.1038/nature10600 pubmed: 22048312 pmcid: 3468323

Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA (2016) Metformin as a tool to target aging. Cell Metab 23:1060–1065. https://doi.org/10.1016/j.cmet.2016.05.011

doi: 10.1016/j.cmet.2016.05.011 pubmed: 27304507 pmcid: 5943638

Blumenthal TH (2003) The aging-disease dichotomy: true or false? J Gerontol A 58:138–145. https://doi.org/10.1093/gerona/58.2.M138

doi: 10.1093/gerona/58.2.M138

Burch JB, Augustine AD, Frieden LA, Hadley E, Howcroft KT, Ron J, Khalsa PS, Kohanski RA, Li XL, Macchiarini F, Niederehe G, Oh YS, Pawlyk AC, Rodriguez H, Rowland JH, Shen GL, Sierra F, Wise BC (2014) Advances in geroscience: impact on healthspan and chronic disease. J Gerontol A 69:S1–S3. https://doi.org/10.1093/gerona/glu041

doi: 10.1093/gerona/glu041

Burd CE, Gill MS, Niedernhofer LJ, Robbins PD, Austad SN, Barzilai N, Kirkland JL (2016) Barriers to the preclinical development of therapeutics that target aging mechanisms. J Gerontol A 71:1388–1394. https://doi.org/10.1093/gerona/glw112

doi: 10.1093/gerona/glw112

Chaib S, Tchkonia T, Kirkland JL (2022) Cellular senescence and senolytics: the path to the clinic. Nat Med 28:1556–1568. https://doi.org/10.1038/s41591-022-01923-y

doi: 10.1038/s41591-022-01923-y pubmed: 35953721 pmcid: 9599677

de Magalhães JP, Stevens M, Thornton D (2017) The business of anti-aging science. Trends Biotechnol 35:1062–1073. https://doi.org/10.1016/j.tibtech.2017.07.004

doi: 10.1016/j.tibtech.2017.07.004 pubmed: 28778607

Demetrius L (2005) Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans. EMBO Rep 6:S39–S44. https://doi.org/10.1038/sj.embor.7400422

doi: 10.1038/sj.embor.7400422 pubmed: 15995660 pmcid: 1369270

Gems D (2015) The aging-disease false dichotomy: understanding senescence as pathology. Front Genet. https://doi.org/10.3389/fgene.2015.00212

doi: 10.3389/fgene.2015.00212 pubmed: 26136770 pmcid: 4468941

Gems D, de Magalhães JP (2021) The hoverfly and the wasp: a critique of the hallmarks of aging as a paradigm. Ageing Res Rev 70:101407. https://doi.org/10.1016/j.arr.2021.101407

doi: 10.1016/j.arr.2021.101407 pubmed: 34271186 pmcid: 7611451

Gems D, Kern CC (2020) Is “cellular senescence” a misnomer? Geroscience 44:2461–2469. https://doi.org/10.1007/s11357-022-00652-x

doi: 10.1007/s11357-022-00652-x

Gill TM (2019) Translational geroscience: challenges and opportunities for geriatric medicine. J Am Geriatr Soc 67:1779–1781. https://doi.org/10.1111/jgs.16056

doi: 10.1111/jgs.16056 pubmed: 31287924 pmcid: 6732027

Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flukey K, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395. https://doi.org/10.1038/nature08221

doi: 10.1038/nature08221 pubmed: 19587680 pmcid: 2786175

Huffman DM, Justice JN, Stout MB, Kirkland JL, Barzilai N, Austad SN (2016) Evaluating health span in preclinical models of aging and disease: guidelines, challenges, and opportunities for geroscience. J Gerontol A 71:1395–1406. https://doi.org/10.1093/gerona/glw106

doi: 10.1093/gerona/glw106

Justice J, Kritchevsky S, Kuchel G, Kirkland J (2020) The translational geroscience network: supporting a new paradigm to alleviate age-related chronic disease. Innov Aging 4:831–831. https://doi.org/10.1093/geroni/igaa057.3042

doi: 10.1093/geroni/igaa057.3042 pmcid: 7743880

Kaeberlein M (2018) How healthy is the healthspan concept? Geroscience 40:361–364. https://doi.org/10.1007/s11357-018-0036-9

doi: 10.1007/s11357-018-0036-9 pubmed: 30084059 pmcid: 6136295

Kaeberlein M, Creevy KE, Promislow DEL (2016) The dog aging project: translational geroscience in companion animals. Mamm Genome 27:279–288. https://doi.org/10.1007/s00335-016-9638-7

doi: 10.1007/s00335-016-9638-7 pubmed: 27143112 pmcid: 4936929

Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI, Pessin JE, Rando TA, Richardson A, Schadt EE, Wyss-Coray T, Sierra F (2014) Geroscience: linking aging to chronic disease. Cell 159:709–713. https://doi.org/10.1016/j.cell.2014.10.039

doi: 10.1016/j.cell.2014.10.039 pubmed: 25417146 pmcid: 4852871

Kenyon CJ (2010) The genetics of ageing. Nature 464:504–512. https://doi.org/10.1038/nature08980

doi: 10.1038/nature08980 pubmed: 20336132

Kern C, Srivastava S, Ezcurra M, Hsiung KC, Hui N, Townsend J, Maczik D, Zhang B, Tse V, Konstantellos V, Bähler J, Gems D (2023) C. elegans ageing is accelerated by a self-destructive reproductive programme. Nat Commun 14:4381. https://doi.org/10.1038/s41467-023-40088-1

doi: 10.1038/s41467-023-40088-1 pubmed: 37474586 pmcid: 10359416

Kowald A, Passos JF, Kirkwood TBL (2020) On the evolution of cellular senescence. Aging Cell 19:e13270. https://doi.org/10.1111/acel.13270

doi: 10.1111/acel.13270 pubmed: 33166065 pmcid: 7744960

Kritchevsky SB, Justice JN (2020) Testing the geroscience hypothesis: early days. J Gerontol A 75:99–101. https://doi.org/10.1093/gerona/glz267

doi: 10.1093/gerona/glz267

Kulkarni AS, Aleksic S, Berger DM, Sierra F, Kuchel GA, Barzilai N (2022) Geroscience-guided repurposing of FDA-approved drugs to target aging: a proposed process and prioritization. Aging Cell. https://doi.org/10.1111/acel.13596

doi: 10.1111/acel.13596 pubmed: 35343051 pmcid: 9009114

Le Bourg E (2016) The somatotropic axis may not modulate ageing and longevity in humans. Biogerontology 14:421–429. https://doi.org/10.1007/s10522-015-9632-6

doi: 10.1007/s10522-015-9632-6

Le Bourg E (2022) Geroscience: the need to address some issues. Biogerontology 23:145–150. https://doi.org/10.1007/s10522-022-09951-4

doi: 10.1007/s10522-022-09951-4 pubmed: 35059905

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039

doi: 10.1016/j.cell.2013.05.039 pubmed: 23746838 pmcid: 3836174

Martin GM (2017) Geroscience: addressing the mismatch between its exciting research opportunities, its economic imperative and its current funding crisis. Exp Gerontol 94:46–51. https://doi.org/10.1016/j.exger.2016.11.008

doi: 10.1016/j.exger.2016.11.008 pubmed: 27871822

Masoro EJ (2005) Overview of caloric restriction and ageing. Mech Ageing Dev 126:913–922. https://doi.org/10.1016/j.mad.2005.03.012

doi: 10.1016/j.mad.2005.03.012 pubmed: 15885745

Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AM, Herbert RL, Longo DL, Allison DB, Young JE, Bryant M, Barnard D, Ward WF, Qi W, Ingram DK, de Cabo R (2012) Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489:318–321. https://doi.org/10.1038/nature11432

doi: 10.1038/nature11432 pubmed: 22932268

Mykytyn CE (2006) Contentious terminology and complicated cartography of anti-aging medicine. Biogerontology 7:279–285. https://doi.org/10.1007/s10522-006-9016-z

doi: 10.1007/s10522-006-9016-z pubmed: 16732402

Newman JC, Milman S, Hashmi SK, Austad SN, Kirkland JL, Halter JB, Barzilai N (2016) Strategies and challenges in clinical trials targeting human aging. J Gerontol A 71:1424–1423. https://doi.org/10.1093/gerona/glw149

doi: 10.1093/gerona/glw149

Newman JC, Sokoloski JL, Robbins PD, Niedernhofer LJ, Reed MJ, Wei J, Austad SN, Barzilai N, Cohen HJ, Kuchel GA, Kirkland JL, Pignolo RJ (2019) Creating the next generation of translational geroscientists. J Am Geriatr Soc 67:1934–1939. https://doi.org/10.1111/jgs.16055

doi: 10.1111/jgs.16055 pubmed: 31287934 pmcid: 6771814

Olshansky SJ, Hayflick L, Carnes BA (2002) Position statement on human aging. J Gerontol A 56:B292-297. https://doi.org/10.1093/gerona/57.8.B292

doi: 10.1093/gerona/57.8.B292

Promislow DEL (2020) A geroscience perspective on COVID-19 mortality. J Gerontol A 75:e30–e33. https://doi.org/10.1093/gerona/glaa094

doi: 10.1093/gerona/glaa094

Rattan SIS (2000) Biogerontology: the next step. Ann N Y Acad Sci 908:282–290. https://doi.org/10.1111/j.1749-6632.2000.tb06655.x

doi: 10.1111/j.1749-6632.2000.tb06655.x pubmed: 10911967

Rattan SIS (2014) Aging is not a disease: implications for intervention. Aging Dis 5:196–202. https://doi.org/10.14336/AD.2014.0500196

doi: 10.14336/AD.2014.0500196 pubmed: 24900942 pmcid: 4037311

Rattan SIS (2020) Naive extrapolations, overhyped claims and empty promises in ageing research and interventions need avoidance. Biogerontology 21:415–421. https://doi.org/10.1007/s10522-019-09851-0

doi: 10.1007/s10522-019-09851-0 pubmed: 31773357

Rattan SIS (2024) Seven knowledge gaps in modern biogerontology. Biogerontology 25:1–8. https://doi.org/10.1007/s10522-023-10089-0

doi: 10.1007/s10522-023-10089-0 pubmed: 38206540

Rolland Y, Sierra F, Luigi F, Barzilai N, De Cabo R, Mannick J, Oliva A, Evans W, Angioni D, De Souto BP, Raffin J, Vellas B, Kirkland JL, the G.C.T-TF group (2023) Challenges in developing geroscience trials. Nat Commun 14:5038. https://doi.org/10.1038/s41467-023-39786-7

doi: 10.1038/s41467-023-39786-7 pubmed: 37598227 pmcid: 10439920

Seals DR, Justice JN, LaRocca TJ (2016) Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity: translational physiology of ageing. J Physiol 594:2001–2024. https://doi.org/10.1113/jphysiol.2014.282665

doi: 10.1113/jphysiol.2014.282665 pubmed: 25639909

Sierra F (2016) The emergence of geroscience as an interdisciplinary approach to the enhancement of health span and life span. Cold Spring Harb Perspect Med 6:a025163. https://doi.org/10.1101/cshperspect.a025163

doi: 10.1101/cshperspect.a025163 pubmed: 26931460 pmcid: 4817738

Sierra F, Kohanski R (2017) Geroscience and the trans-NIH Geroscience Interest Group, GSIG. GeroScience 39:1–5. https://doi.org/10.1007/s11357-016-9954-6

doi: 10.1007/s11357-016-9954-6 pubmed: 28299635 pmcid: 5352582

Sholl J (2017) The muddle of medicalization: pathologizing or medicalizing? Theor Med Bioeth 38:265–278. https://doi.org/10.1007/s11017-017-9414-z

doi: 10.1007/s11017-017-9414-z pubmed: 28674861

Sonntag WE, Ungvari Z (2016) GeroScience: understanding the interaction of processes of aging and chronic diseases. Age 38:377–378. https://doi.org/10.1007/s11357-016-9953-7

doi: 10.1007/s11357-016-9953-7 pubmed: 27924421 pmcid: 5266222

Stambler I (2020) History of life-extensionism. In: Rattan SIS, Barbagallo M, Le Bourg E (eds) Encyclopedia of biomedical gerontology, vol 2. Academic Press, London, pp 228–237

Zerhouni E (2003) The NIH roadmap. Science 302:63–72. https://doi.org/10.1126/science.1091867

doi: 10.1126/science.1091867 pubmed: 14526066